 |
|
Ocular VacciniaAn Epidemiologic Analysis of 348 Cases
Frederick L. Ruben, MD;
J. Michael Lane, MD, MPH
Arch Ophthalmol. 1970;84(1):45-48.
Abstract
Three hundred and twenty-six cases of ocular vaccinia and 22 cases of corneal vaccinia were detected by follow-up of patients receiving vaccinia immune globulin. The majority of these patients (70%) were primary vaccinees; over half had onset seven to ten days after vaccination. Nineteen percent acquired vaccinia from other vaccinated people. Fifty-eight percent of all patients were under 4 years of age, and 57% of all patients were female. Underlying conditions predisposing to vaccinia were infrequent. Residua in noncorneal cases were rare (2%); 18% of the corneal cases had residua. No residua were severe.
Author Affiliations
Atlanta
From the Domestic Branch of the Smallpox Eradication Program, National Communicable Disease Center, Atlanta.
Footnotes
Submitted for publication Jan 26, 1970.
Reprint requests to National Communicable Disease Center, Building 1, Room 453, Atlanta 30333 (Dr. Ruben).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Neurologic Adverse Events Associated With Smallpox Vaccination in the United States, 2002-2004
Sejvar et al.
JAMA 2005;294:2744-2750.
ABSTRACT
| FULL TEXT
The Ocular Complications of Smallpox and Smallpox Immunization
Smith et al.
Arch Ophthalmol 2004;122:1407-1407.
FULL TEXT
The Ocular Complications of Smallpox and Smallpox Immunization
Semba
Arch Ophthalmol 2003;121:715-719.
ABSTRACT
| FULL TEXT
Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options
Lane and Goldstein
ANN INTERN MED 2003;138:488-493.
ABSTRACT
| FULL TEXT
Eyelids, Lacrimal Apparatus, and Conjunctiva
Sexton
Arch Ophthalmol 1971;85:379-396.
|
